MENU
EPRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Eupraxia Pharmaceuticals (EPRX) Ownership - Who owns Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals... Show more
Profile
Industry
N/A
Address
201-2067 Cadboro Bay Road
Phone
+1 250 590-3968
Employees
21
Web
https://www.eupraxiapharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
191.82M
P/E Ratio
N/A
Total Cash
19.77M
Projected Growth
N/A
Total Debt
35.07K
Revenue
N/A
Risk (Beta)
3.73
Dividend Yield
N/A
Total Cash/Share
0.55
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
EPRX
Capitalization
192M
P/E Ratio
N/A
Risk (Beta)
3.73
Dividend Yield
N/A
Total Cash
19.8M
Total Cash/Share
0.55
Total Debt
35.1K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-9.15M
P/B Ratio
80.00
Cash Flow
N/A
Earnings
-0.86
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
117M
Current Ratio
8.72
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-28.83M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-119.23
Shares Held By Institutions
11.2M
Shares Outstanding - Current
36M
Total Liabilities
2.62M
Total Volume MTD
N/A
Value
-1
Gain YTD
70.032
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EPRX showed earnings on August 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
201-2067 Cadboro Bay Road
Phone
+1 250 590-3968
Employees
21
Web
https://www.eupraxiapharma.com